APPLIED THERAPEUTICS INC(NASDAQ:APLT) stock News

APLT Latest News, Press Relases and Analysis

All

Press Releases

14 hours ago - By: Benzinga - Mentions: CSCI EVOK NXL ZYME ...

12 Health Care Stocks Moving In Friday's After-Market Session

10 days ago - By: The Motley Fool

Applied Therapeutics Reports Q2 Loss

10 days ago - By: Applied Therapeutics

Applied Therapeutics Reports Second Quarter 2025 Financial Results

10 days ago - By: Applied Therapeutics

Applied Therapeutics Reports Second Quarter 2025 Financial Results

2 months ago - By: Applied Therapeutics

Applied Therapeutics Announces Key Leadership Appointments

2 months ago - By: Applied Therapeutics

Applied Therapeutics Announces Key Leadership Appointments

3 months ago - By: Benzinga - Mentions: NVAX PTIX RGC ABP ...

12 Health Care Stocks Moving In Monday's Intraday Session

3 months ago - By: Applied Therapeutics

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

3 months ago - By: Applied Therapeutics

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

3 months ago - By: Applied Therapeutics

Applied Therapeutics Reports First Quarter 2025 Financial Results

3 months ago - By: Applied Therapeutics

Applied Therapeutics Reports First Quarter 2025 Financial Results

4 months ago - By: Applied Therapeutics

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

4 months ago - By: Applied Therapeutics

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

4 months ago - By: Zacks Investment Research - Mentions: RYTM

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates

4 months ago - By: Applied Therapeutics

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

4 months ago - By: Applied Therapeutics

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

5 months ago - By: Applied Therapeutics

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

5 months ago - By: Applied Therapeutics

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

5 months ago - By: Applied Therapeutics

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

5 months ago - By: Applied Therapeutics

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

6 months ago - By: Faruqi & Faruqi, LLP

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics

6 months ago - By: Levi & Korsinsky, LLP

Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky

6 months ago - By: The Rosen Law Firm PA

APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT

6 months ago - By: Robbins Geller Rudman & Dowd LLP

INVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLT

6 months ago - By: Kessler Topaz Meltzer & Check, LLP

APLT Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit

6 months ago - By: THE ROSEN LAW FIRM, P. A.

APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit

6 months ago - By: The Rosen Law Firm, P.A.

APPLIED THERAPEUTICS INC (APLT) Stock News

APLT Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Friday's After-Market Session

Applied Therapeutics Reports Q2 Loss

Applied Therapeutics Reports Second Quarter 2025 Financial Results

Applied Therapeutics Reports Second Quarter 2025 Financial Results

Applied Therapeutics Announces Key Leadership Appointments

Applied Therapeutics Announces Key Leadership Appointments

12 Health Care Stocks Moving In Monday's Intraday Session

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Reports First Quarter 2025 Financial Results

Applied Therapeutics Reports First Quarter 2025 Financial Results

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics

Class Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky

APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT

INVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - APLT

APLT Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit

APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit

APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights